1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 2: Patient characteristics
Characteristic Sex (female/male ratio) 8:17 Age on follow-up MRI (range) (yr) 66 (39–86) MRI examinations (No.) (%)a 1 Time 19 (76) 2 Times 3 (12) 3 Times 2 (8) 4 Times 1 (4) Follow-up period (range) (mo) 33 ± 35 (0.5–142) Symptom on admission (No.) (%) None 15 (43) Pure motor 16 (46) Hemiplegia 2 (6) Hemianopsia 2 (6) Vascular risk factors (No.) (%) DM 8 (32) HL 3 (12) HT 12 (48) Smoking 6 (24)
Note:—DM indicates diabetes mellitus; HL, hyperlipidemia; HT, hypertension.
↵a Number of initial MRI examination per patients.